BUY 75MCGÂ ONnsdermal System (CII) is indicated for the management of pain in -tolerant patients, severe enough to require daily, around-the-clock, long-term treatment and for which alternative treatment options are inadequate.
Patients considered -tolerant are those who are taking, for one week or longer, at least 60 mg of daily, or at least 30 mg of oral daily, or at least 8 mg of oral hydromordaily, or an equianalgesic dose of another .
IF interested, add me on
Signup today to claim your Discount. Get Started before it's too late!
